Direct Comparison Of Binding Affinities From Spectral Shift And SPR For Biotinylated Targets

Drug discovery is increasingly complex, with researchers facing challenging targets like intrinsically disordered or catalytically inert proteins. No single screening method works for every scenario, making it essential to diversify your approach. This infographic highlights a direct comparison of binding affinities using Spectral Shift technology and Surface Plasmon Resonance (SPR) for biotinylated targets.

With the Biotinylated Target Labeling Kit, you can maximize efficiency by using the same biotinylated protein stock already in your freezer for both techniques. Spectral Shift enables rapid single-dose screening of 384 compounds in just 30 minutes, while SPR provides a thorough interaction analysis in 240 minutes.

Comparing these methods side by side helps you validate leads with greater confidence, offering alternative solutions when one approach falls short. Whether you need quick insights or in-depth interaction analysis, this infographic breaks down the workflows and benefits of each technology. Learn how to optimize your screening and validation process to tackle even the most challenging molecular interactions.